Status:
UNKNOWN
Diastology-Guided Management of Decompensated Heart Failure
Lead Sponsor:
McMaster University
Conditions:
Heart Failure
Diastolic Dysfunction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
More than 30% of people hospitalized with decompensated heart failure return to the hospital within 90 days. Emerging evidence suggests that hemodynamic monitoring with guided management may enhance p...
Eligibility Criteria
Inclusion
- Age ≥18 years at the time of enrolment
- Decompensated heart failure with reduced ejection fraction (≤40%)
- Sinus rhythm without conduction abnormalities (second-degree Mobitz II, third-degree, permanent pacemaker)
- Written informed consent from either the patient or a substitute decision maker
Exclusion
- Mitral annular calcification (at least moderate or severe)
- Moderate or severe aortic or mitral valvular heart disease, or history of prosthetic mitral valve
- Atrial fibrillation or flutter
- History of non-diagnostic echocardiogram
- Hemodialysis
Key Trial Info
Start Date :
November 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06131008
Start Date
November 6 2023
End Date
July 31 2024
Last Update
November 14 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.